316 related articles for article (PubMed ID: 18096852)
1. Tacrolimus for myasthenia gravis: a clinical study of 212 patients.
Ponseti JM; Gamez J; Azem J; López-Cano M; Vilallonga R; Armengol M
Ann N Y Acad Sci; 2008; 1132():254-63. PubMed ID: 18096852
[TBL] [Abstract][Full Text] [Related]
2. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
[TBL] [Abstract][Full Text] [Related]
3. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
[TBL] [Abstract][Full Text] [Related]
4. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
[TBL] [Abstract][Full Text] [Related]
6. Transsternal thymectomy for myasthenia gravis: surgical outcome.
Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
[TBL] [Abstract][Full Text] [Related]
7. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
Minami N; Fujiki N; Doi S; Shima K; Niino M; Kikuchi S; Sasaki H
J Neurol Sci; 2011 Jan; 300(1-2):59-62. PubMed ID: 21035148
[TBL] [Abstract][Full Text] [Related]
9. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis.
Furukawa Y; Yoshikawa H; Iwasa K; Yamada M
J Neuroimmunol; 2008 Mar; 195(1-2):108-15. PubMed ID: 18262659
[TBL] [Abstract][Full Text] [Related]
11. Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study.
Ponseti JM; Azem J; Fort JM; Codina A; Montoro JB; Armengol M
Clin Neurol Neurosurg; 2005 Apr; 107(3):187-90. PubMed ID: 15823673
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
Huang CS; Hsu HS; Huang BS; Lee HC; Kao KP; Hsu WH; Huang MH
Acta Neurol Scand; 2005 Aug; 112(2):108-14. PubMed ID: 16008537
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis.
Zhao CB; Zhang X; Zhang H; Hu XQ; Lu JH; Lu CZ; Xiao BG
Int Immunopharmacol; 2011 Apr; 11(4):519-24. PubMed ID: 21195813
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
[TBL] [Abstract][Full Text] [Related]
15. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
[TBL] [Abstract][Full Text] [Related]
16. Effects of thymectomy on late-onset myasthenia gravis without thymoma.
Kawaguchi N; Kuwabara S; Nemoto Y; Fukutake T; Arimura K; Osame M; Hattori T
Clin Neurol Neurosurg; 2007 Dec; 109(10):858-61. PubMed ID: 17904281
[TBL] [Abstract][Full Text] [Related]
17. Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma.
Kim HK; Park MS; Choi YS; Kim K; Shim YM; Han J; Kim BJ; Kim J
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):601-7. PubMed ID: 17723805
[TBL] [Abstract][Full Text] [Related]
18. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
[TBL] [Abstract][Full Text] [Related]
19. Outcome after transsternal radical thymectomy for myasthenia gravis: 14-year review at Ratchaburi Hospital.
Glinjongol C; Paiboonpol S
J Med Assoc Thai; 2004 Nov; 87(11):1304-10. PubMed ID: 15825704
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis.
Pompeo E; Tacconi F; Massa R; Mineo D; Nahmias S; Mineo TC
Eur J Cardiothorac Surg; 2009 Jul; 36(1):164-9. PubMed ID: 19339195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]